60
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Performance Impacts of Nerve Agents and Their Pharmacological Countermeasures

Pages 93-119 | Published online: 17 Nov 2009

REFERENCES

  • Ames, R., Steenland, K., Jenkins, B., Chrislop, D., & Russo, J. (1995). Chronic neurological sequelae to cholinesterase inhibition among agricultural pesticide applicators. Archives of Environmental Health, 50, 440–443.
  • Ashton, H. (1994). The treatment of benzodiazepine dependence. Addiction, 89, 1535–1541.
  • Baghdoyan, H. A., Monaco, A. P., Rodrigo-Angulo, M. L., Assens, F., McCarley, R. W., & Hobson, J. A. (1984). Microinjections of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs. Journal of Pharmacology and Experimental Therapeutics, 231, 173–180.
  • Baker, R., Adams, A., Jampolsky, A., Brown, B., Haegerstrom-Portnoy, G., & Jones, R. (1983). Effects of atropine on visual performance. Military Medicine, 148, 530–535.
  • Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408–417.
  • Bowers, M. B., Goodman, E., & Sim, V. M. (1964). Some behavioral changes in man following anticholinesterase administration. Journal of Nervous and Mental Disorders, 138, 383–389.
  • Brimblecombe, R. W. (1974). Drug action on cholinergic systems. Baltimore: University Park Press.
  • Burchfiel, J. L., Duffy, F. H., & Sim, V. M. (1976). Persistent effects of sarin and dieldrin upon the primate electroencephalogram. Toxicology and Applied Pharmacology, 35, 365–379.
  • Caldwell, J. A., Stephens, R. L., Carter, D. J., & Jones, H. D. (1992). Effects of 2 mg and 4 mg atropine sulfate on the performance of U.S. Army helicopter pilots. Aviation, Space, and Environmental Medicine, 63, 857–864.
  • Calesnick, B., Christensen, J. A., & Richter, M. (1967). Human toxicity of various oximes. Archives of Environmental Health, 15, 599–608.
  • Cook, J. E., Kolka, M. A., & Wenger, C. B. (1992). Chronic pyridostigmine bromide administration: Side effects among soldiers working in a desert environment. Military Medicine, 157, 250–254.
  • Craig, A. B., & Freeman, G. (1953). Clinical observations in workers accidentally exposed to “G”-agents (Medical Laboratory Res. Rep. No. 154). Aberdeen Proving Ground, MD: Edgewood Arsenal.
  • Davis, K. L., Berger, P. A., Hollister, L. E., & Barchas, J. D. (1978). Cholinergic involvement in mental disorders. Life Sciences, 22, 1865–1871.
  • Dawson, R. M. (1994). Review of oximes available for treatment of nerve agent poisoning. Journal of Applied Toxicology, 14, 317–331.
  • DeCandole, C. A., Douglas, W. W., Evans, C. L., Holmes, R., Spencer, K. E. V., Torrance, R. W., etal. (1953). The failure of respiration in death by anticholinesterase poisoning. British Journal of Pharmacology, 8, 466–475.
  • Duffy, F. H., Burchfiel, J. L., Bartels, P. H., Gaon, M., & Sim, V. M. (1979). Long-term effects of an organophosphate upon the human encephalogram. Toxicology and Applied Pharmacology, 47, 161–176.
  • Dunn, M. A., Hackley, B. E., Jr., & Sidell, F. R. (1997). Pretreatment for nerve agent exposure. In R. Zajtchuk (Ed.), Textbook of military medicine: Medical aspects of chemical and biological warfare (pp. 181–196). Washington, DC: Office of the Surgeon General.
  • Forster, E. M., Barber, J. A., Parker, F. R., Jr., Whinnery, J. E., Burton, R. R., & Boll, P. (1994). Effect of pyridostigmine bromide on acceleration tolerance and performance. Aviation, Space, and Environmental Medicine, 65, 110–116.
  • Gall, D. (1981). The use of therapeutic mixtures in the treatment of cholinesterase inhibition. Fundamental and Applied Pharmacology, 1, 214–216.
  • Gawron, V. J., Schiflett, S. G., Miller, J. C., Slater, T., & Ball, J. F. (1990). Effects of pyridostigmine bromide on in-flight aircrew performance. Human Factors, 32, 79–94.
  • George, R., Haslett, W. L., & Jenden, D. J. (1964). A cholinergic mechanism in the brainstem reticular formation: Induction of paradoxical sleep. International Journal of Neuropharmacology, 3, 541–552.
  • Ghoneim, M. M., Hinrichs, J. V., & Mewaldt, M. P. (1984). Dose-response analysis of the behavioral effects of diazepam: I. Learning and memory. Psychopharmacology, 82, 291–295.
  • Gillin, J. C., Sitram, N., Mendelson, W. B., & Wyatt, R. J. (1978). Physostigmine alters onset but not duration of REM sleep in man. Psychopharmacology, 58, 111–114.
  • Glenn, J. F., Hinman, D. J., & McMaster, S. B. (1987). Electroencephalographic correlates of nerve agent poisoning. In N. J Dun & R. L. Perlman (Eds.), Neurobiology of acetylcholine (pp. 503–534). New York: Plenum.
  • Gnadt, J. W., Atwood, C. W., Meighen, G. A., & Pegram, G. V. (1986). Di-isopropyl-fluorophosphate (DFP): Acute toxicity and sleep. Neurotoxicology, 7, 165–172.
  • Gnadt, J. W., & Pegram, G. V. (1986). Cholinergic brainstem mechanisms of REM sleep in the rat. Brain Research, 384, 29–41.
  • Gnadt, J. W., Pegram, G. V., & Baxter, J. F. (1985). The acetylcholinesterase inhibitor di-isopropyl-fluorophosphate increases REM sleep in rats. Physiology and Behavior, 35, 911–916.
  • Gorissen, M. E., Curran, H. V., & Eling, P. A. (1998). Proactive interference and temporal context encoding after diazepam intake. Psychopharmacology, 138, 334–343.
  • Gorissen, M. E., & Eling, P. A. (1998). Dual task performance after diazepam intake: Can resource depletion explain the benzodiazepine-induced amnesia? Psychopharmacology, 138, 354–361.
  • Gorissen, M. E., Tielemans, M., & Coenen, A. (1997). Alertness and memory after sleep deprivation and diazepam intake. Journal of Psychopharmacology, 11, 233–239.
  • Gouge, S. F., Daniels, D. J., & Smith, C. E. (1994). Exacerbation of asthma after pyridostigmine during Operation Desert Storm. Military Medicine, 159, 108–111.
  • Grob, D., & Harvey, A. M. (1953). The effects and treatment of nerve gas poisoning. American Journal of Medicine, 14, 52–63.
  • Grob, D., & Harvey, A. M. (1958). Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate). Journal of Clinical Investigations, 37, 350–368.
  • Grob, D., Harvey, A. M., Langworthy, O. R., & Lilenthal, J. L. (1947). The administration of di-isopropyl flurophosphate (DFP) to man: III. Effect on the central nervous system with special reference to the electrical activity of the brain. Bulletin of the Johns Hopkins Hospital, 81, 257–266.
  • Haegerstrom-Portnoy, G., Jones, R., Adams, A., & Jampolsky, A. (1987). Effects of atropine and 2-PAM Cl on vision and performance in humans. Aviation, Space, and Environmental Medicine, 58, 47–53.
  • Hatta, K., Miura, Y., Asukai, N., & Harnabe, Y. (1996). Amnesia from sarin poisoning. Lancet, 347, 1343.
  • Hayes, W. (1982). Pesticides studied in man. Baltimore: Williams & Wilkins.
  • Headley, D. B. (1982). Effects of atropine sulfate and pralidoxime chloride on visual, physiological, performance, subjective, and cognitive variables in man: A review. Military Medicine, 147, 122–132.
  • Higgins, S. T., Woodward, B. M., & Henningfield, J. E. (1989). Effects of atropine on the repeated acquisition and performance of response sequences in humans. Journal for the Experimental Analysis of Behavior, 51, 5–15.
  • Hinrichs, J. V., Mewaldt, S. P., Ghoneim, M. M., & Berie, J. L. (1982). Diazepam and learning: Assessment of acquisition deficits. Pharmacology Biochemistry and Behavior, 17, 165–170.
  • Hobson, J. A. (1992). Sleep and dreaming: Induction and mediation of REM sleep by cholinergic mechanisms. Current Opinions in Neurobiology, 2, 759–763.
  • Holmes, J. H., & Gaon, M. D. (1956). Observations on acute and multiple exposure to anticholinesterase agents. Transactions of the American Clinical and Climatology Society, 68, 86–101.
  • Izraeli, S., Avgar, D., Almog, S., Shochat, I., Tochner, Z., Tamir, A., etal. (1990). The effect of repeated doses of 30 mg pyridostigmine bromide on pilot performance in an A-4 flight simulator. Aviation, Space, and Environmental Medicine, 61, 430–432.
  • Janowsky, D. S., & Overstreet, D. H. (1990). Cholinergic dysfunction in depression. Pharmacologyand Toxicology, 66, 100–111.
  • Janowsky, D. S., Risch, S. C., & Gillin, J. C. (1983). Adrenergic-cholinergic balance and the treatment of affective disorders. Progress in Neuropsychopharmacology and Biological Psychiatry, 7, 297–307.
  • Kato, T., & Hamanaka, T. (1996). Ocular signs and symptoms caused by exposure to sarin gas. American Journal of Ophthalmology, 121, 209–210.
  • Kay, C. D., & Morrison, J. D. (1988). The effects of ingestion of 60 mg pyridostigmine bromide on contrast sensitivity in man. Human Toxicology, 7, 347–352.
  • Keeler, J. R. (1990). Interactions between nerve agent pretreatment and drugs commonly used in combat anesthesia. Military Medicine, 155, 527–533.
  • Keeler, J. R., Hurst, C. G., & Dunn, M. A. (1991). Pyridostigmine used as a nerve agent pretreatment under war time conditions. Journal of the American Medical Association, 266, 693–695.
  • Ketchum, J. S., Sidell, F. R., Crowell, E. B., Jr., Aghajanian, G. K., & Hayes, A. H., Jr. (1973). Atropine, scopolamine, and ditran: Comparative pharmacology and antagonists in man. Psychopharmacologia, 28, 121–145.
  • Kleinknecht, R. A., & Donaldson, D. (1975). A review of the effects of diazepam on cognitive and pyschomotor performance. Journal of Nervous and Mental Disorders, 161, 399–414.
  • Kobrick, J. L., Johnson, R. F., & McMenemy, D. J. (1990). Effects of nerve agent antidote and heat exposure on soldier performance in the BDU and MOPP-IV ensembles. Military Medicine, 155, 159–162.
  • Koelega, H. S. (1989). Benzodiazepines and vigilance performance: A review. Psychopharmacology, 98, 145–156.
  • Koelle, G. B. (1963). Cholinesterases and anticholinesterase agents. In O. Eichler & A. Farah (Eds.), Handbuch der Experimentellen Pharmakologie (Vol. 15). Berlin, Germany: Springer-Verlag.
  • Kolka, M. A., & Stephenson, L. A. (1990). Human temperature regulation during exercise after oral pyridostigmine administration. Aviation, Space, and Environmental Medicine, 61, 220–224.
  • Korsak, R. J., & Sato, M. M. (1977). Effects of chronic organophosphate pesticide exposure onthe central nervous system. Clinical Toxicology, 11, 83–95.
  • Krueger, G. P., & Banderet, L. E. (1997). Effects of chemical protective clothing on military performance: A review of the issues. Military Psychology, 9, 255–286.
  • Longo, V. G. (1966). Behavioral and electroencephalographic effects of atropine and related compounds. Pharmacological Reviews, 18, 965–996.
  • Masuda, N., Takatsu, M., Morinari, H., & Ozawa, T. (1995). Sarin poisoning in Tokyo subway. Lancet, 345, 1446.
  • McDonough, J. H., & Shih, T. M. (1997). Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neuroscience and Biobehavioral Reviews, 21, 559–579.
  • Medical management of chemical casualties handbook. (3rd ed.) (1999). Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense, Chemical Casualty Care Office.
  • Metcalf, D. R., & Holmes, J. W. (1969). EEG, psychological, and neurological alterations in humans with organophosphorus exposure. Annals of the New York Academy of Science, 160, 357–365.
  • Mewaldt, S. P., & Ghoneim, M. M. (1979). The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory. Pharmacology Biochemistry and Behavior, 10, 205–210.
  • Moore, D. H., Clifford, C. B., Crawford, I. T., Cole, G. M., & Baggett, J. M. (1995). Review of nerve agentinhibitors and reactivators of acetylcholinesterase. In D. M Quinn, A. S. Balasubramanian, B. P. Doctor, & P. Taylor (Eds.), Enzymes of cholinesterase family (pp. 297–304). New York: Plenum.
  • Morita, H., Yanaagisawa, N., Nakajima, T., Shimizu, M., Hirabayashi, H., Okudera, H., et al. (1995). Sarin poisoning in Masumoto, Japan. Lancet, 346, 290–293.
  • Moylan-Jones, R. J. (1969). The effect of a large dose of atropine on the performance of routine tasks. British Journal of Pharmacology, 37, 301–305.
  • Moylan-Jones, R. J., & Thomas, D. P. (1973). Cyclopentolate in treatment of sarin miosis. British Journal of Pharmacology, 48, 309–313.
  • Murray, J. T. (1984). Effects of valium and librium on human psychomotor and cognitive functions. Genetic Psychology Monographs, 109, 167–197.
  • Nakajima, T., Ohta, S., Morita, H., Midorikawa, Y., Mimura, S., & Yanagisawa, N. (1997). Epidemio-logical study of sarin poisoning in Matsumoto City, Japan. Journal of Epidemiology, 8, 33–41.
  • National Research Council. (1982). Possible long-term health effects of short-term exposure to chemical agents: Vol. 1. Anticholinesterases and anticholinergics. Washington, DC: National Academy Press.
  • Nozaki, H., & Aikawa, N. (1995). Sarin poisoning in Tokyo subway. Lancet, 345, 1446–1447.
  • Nozaki, H., Aikawa, N., Fujishima, S., Suzuki, M., Shinozawa, Y., Hori, S., et al. (1995). A case of VX poisoning and the difference from sarin. Lancet, 346, 698–699.
  • Ohbu, S., Yamashina, A., Takasu, N., Yamaguchi, T., Murai, T., Nakano, K., et al. (1997). Sarin poisoning on Tokyo subway. Southern Medical Journal, 90, 587–593.
  • Okumura, T., Takasu, N., Ishimatsu, S., Miyanoki, S., Mitsuhashi, A., Kumada, K., et al. (1996). Report on 640 victims of the Tokyo subway sarin attack. Annals of Emergency Medicine, 28, 129–135.
  • Penetar, D. M. (1990). A brief review of atropine effects on physiology and performance. Drug Development Research, 20, 117–121.
  • Penetar, D. M., & Beatrice, E. S. (1986). Effects of atropine on human pursuit tracking performances. Aviation, Space, and Environmental Medicine, 57, 654–658.
  • Penetar, D. M., Haegerstrom-Portnoy, G., & Jones, R. T. (1988). Combined atropine and 2-PAM Cl effects on tracking performance and visual, physiological, and psychological functions. Aviation, Space, and Environmental Medicine, 59, 1125–1132.
  • Penetar, D. M., & McDonough, J. H. (1983). Effects of cholinergic drugs on delayed match-to-sample performance of rhesus monkeys. Pharmacology Biochemistry and Behavior, 19, 963–967.
  • Pickworth, W. B., Herning, R. I., Koeppl, B., & Henningfield, J. E. (1990). Dose-dependent atropine-induced changes in spontaneous electroencephalogram in human volunteers. Military Medicine, 155, 166–170.
  • Rengstorff, R. H. (1985). Accidental exposure to sarin. Archives of Toxicology, 56, 201–203.
  • Rickett, D. L., Glenn, J. F., & Beers, E. T. (1986). Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology, 7, 225–236.
  • Rosenstock, L., Keifer, M., Daniell, W. E., McConnell, R., & Claypoole, K. (1991). Chronic central nervous system effects of acute organophosphate pesticide intoxication. Lancet, 338, 223–227.
  • Roy-Byrne, P. P., Uhde, T. W., Holcomb, H., Thompson, K., King, A. K., & Weingartner, H. (1987). The effects of diazepam on cognitive process in normal subjects. Psychopharmacology, 91, 30–33.
  • Rubin, L. S., & Goldberg, M. N. (1958). Effect of tertiary and quaternary atropine salts on absolute scotopic threshold changes produced by an anticholinesterase (sarin). Journal of Applied Physiology, 12, 302–310.
  • Rubin, L. S., Krop, S., & Goldberg, M. N. (1957). Effect of sarin on dark adaptation in man. Journal of Applied Physiology, 11, 445–449.
  • Savage, E. P., Keefe, T. J., Mounce, L. M., Heaton, R. K., Lewis, J. A., & Burcar, P. J. (1988). Chronic neurological sequelae of acute organophosphate pesticide poisoning. Archives of Environmental Health, 43, 38–45.
  • Schiflett, S. G., Stranges, S. F., Slater, T., & Jackson, M. K. (1987). Interactive effects of pyridostigmine and altitude on performance. In Proceedings of the 6th Medical Chemical Defense Bioscience Review (pp. 605–607). Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense. (DTIC No. AD-B121 516)
  • Sekijima, Y., Morita, H., Shindo, M., Okudera, H., Shibata, T., & Yanagisawa, N. (1995). A case of severe sarin poisoning in the sarin attack at Matsumoto—One-year follow-up on the clinical findings and laboratory data. Rinsho Shinkeijaku, 35, 1241–1245.
  • Sharabi, Y., Danon, Y. L., Berkenstadt, H., Almog, S., Mimouni-Bloch, A., Zisman, A., et al. (1991). Survey of symptoms following intake of pyridostigmine during the Persian Gulfwar. Israel Journal of Medical Science, 27, 656–658.
  • Shih, T. M., Koviak, T. A., & Capacio, B. R. (1991). Anticonvulsants for poisoning by the organophosphorus compound soman: Pharmacological mechanisms. Neuroscience and Biobehavioral Reviews, 15, 349–362.
  • Shih, T. M., & McDonough, J. H. (1997). Neurochemical mechanisms in soman-induced seizures. Journal of Applied Toxicology, 17, 255–264.
  • Shih, T. M., McDonough, J. H., & Koplovitz, I. (1999). Anticonvulsants for soman-induced seizure activity. Journal of Biomedical Science, 6, 86–96.
  • Sidell, F. R. (1974). Soman and sarin: Clinical manifestations and treatment of accidental poisoning by organophosphates. Clinical Toxicology, 7, 1–17.
  • Sidell, F. R. (1992). Clinical considerations in nerve agent intoxication. In S. Somani (Ed.), Chemical warfare agents (pp. 155–194). New York: Academic.
  • Sidell, F. R. (1996). A history of human studies with nerve agents by the UK and USA. In T. C. Marrs, R. L. Maynard, & F. R. Sidell (Eds.), Chemical warfare agents: Toxicology and treatment (pp. 115–137). Chichester, England: Wiley.
  • Sidell, F. R. (1997). Nerve agents. In R. Zajtchuk (Ed.), Textbook of military medicine: Medical aspects of chemical and biological warfare (pp. 129–179). Washington, DC: Office of the Surgeon General.
  • Sidell, F. R., & Groff, W. A. (1971). Intramuscular and intravenous administrations of small doses of 2-pyridinium aldoxime methochloride to man. Journal of Pharmaceutical Science, 60, 1224–1228.
  • Sidell, F. R., Groff, W. A., & Ellin, R. I. (1969). Blood levels of oxime and symptoms in humans after single and multiple oral doses of 2-pyridine aldoxime methochloride. Journal of Pharmaceutical Science, 58, 1093–1098.
  • Simmons, R. R., Caldwell, J. A., Stephens, R. L., Stone, L. W., Carter, D. J., Behar, I., et al. (1989). Effects of the chemical defense antidote atropine sulfate on helicopter pilot performance: A simulator study (USAARLTech. Rep. No. 89–17). Fort Rucker, AL: U.S. Army Aeromedical Research Laboratory.
  • Sitram, N., Wyatt, R. J., Dawson, S., & Gillin, J. G. (1976). REM sleep induction by physostigmine infusion during sleep. Science, 191, 1281–1283.
  • Smiley, A. (1987). Effects of minor tranquilizers and antidepressants on psychomotor performance. Journal of Clinical Psychiatry, 48, 22–28.
  • Somani, S. M., Solana, R. P., & Dube, S. N. (1992). Toxicodynamics of nerve agents. In S. Somani (Ed.), Chemical warfare agents (pp. 68–123). New York: Academic.
  • Stephens, R., Spurgeon, A., Calvert, I. A., Beach, J., Levy, L. S., Berry, H., et al. (1995). Neuropsychological effects of long-term exposure to organophosphates in sheep dip. Lancet, 345, 1135–1139.
  • Stephenson, L. A., & Kolka, M. A. (1990). Acetylcholinesterase inhibitor, pyridostigmine bromide, reduces skin blood flow in humans. American Journal of Physiology, 258, R951–R957.
  • Stewart, W. C., Madill, H. D., & Dyer, A. M. (1968). Nightvision in the miotic eye. CanadianMedical Association Journal, 99, 1145–1148.
  • Stokes, L., Stark, A., Marshall, E., & Narang, A. (1995). Neurotoxicity among pesticide applicators exposed to organophosphates. Occupational and Environmental Medicine, 52, 648–653.
  • Sundwall, A. (1961). Minimum concentrations of n-methylpyridinium-2-aldoxime methan sulphonate (P2S) which reverse neuromuscular block. Biochemical Pharmacology, 8, 413–417.
  • Taylor, P. (1985). Anticholinesterase agents. In A. G Gilman, L. S. Goodman, T. W. Rall, & F. Murad (Eds.), The pharmacological basis of therapeutics (6th ed., pp. 110–129). New York: Macmillan.
  • Voytko, M. L. (1996). Cognitive functions of the basal forebrain cholinergic system in monkeys: Memory or attention? Behavioral Brain Research, 75, 13–25.
  • Wenger, B., Quigley, M. D., & Kolka, M. A. (1993). Seven-day pyridostigmine administration and thermoregulation during rest and exercise in dry heat. Aviation, Space, and Environmental Medicine, 64, 905–911.
  • Wetherell, A. (1980). Some effects of atropine on short-term memory. British Journal of Clinical Pharmacology, 10, 627–628.
  • Wright, P. G. (1954). An analysis of the central and peripheral components of respiratory failure produced by anticholinesterase poisoning in the rabbit. Journal of Physiology, 126, 52–70.
  • Yokoyama, K., Araki, S., Murata, K., Nishikitani, M., Okumura, T., Ishimatsu, S., et al. (1998a). Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning. Journal of Physiology (Paris), 92, 317–323.
  • Yokoyama, K., Araki, S., Murata, K., Nishikitani, M., Okumura, T., Ishimatsu, S., etal. (1998b). Apre-liminary study on delayed vestibulocerebellar effects of Tokyo subway sarin poisoning in relation to gender difference: Frequency analysis of postural sway. Journal of Occupational and Environmental Medicine, 40, 17–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.